Cargando…
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida
IMPORTANCE: Patients with cancer experience high rates of morbidity and mortality after SARS-CoV-2 infection. Immune response to mRNA-1273 vaccination across multiple cancer types and treatments remains to be established. OBJECTIVE: To quantitate antibody responses after mRNA-1273 vaccination among...
Autores principales: | Giuliano, Anna R., Lancet, Jeffrey E., Pilon-Thomas, Shari, Dong, Ning, Jain, Akriti G., Tan, Elaine, Ball, Somedeb, Tworoger, Shelley S., Siegel, Erin M., Whiting, Junmin, Mo, Qianxing, Cubitt, Christopher L., Dukes, Christopher W., Hensel, Jonathan A., Keenan, Robert J., Hwu, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914884/ https://www.ncbi.nlm.nih.gov/pubmed/35266953 http://dx.doi.org/10.1001/jamaoncol.2022.0001 |
Ejemplares similares
-
Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients
por: Giuliano, Anna, et al.
Publicado: (2023) -
Immunogenicity of Sars-Cov-2 mRNA 1273 Vaccine in Patients with Lymphoid Malignancies
por: Dong, Ning, et al.
Publicado: (2021) -
Long-Term CD4(+) T-Cell and Immunoglobulin G Immune Responses in Oncology Workers following COVID-19 Vaccination: An Interim Analysis of a Prospective Cohort Study
por: Gallen, Corey, et al.
Publicado: (2022) -
SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020–March 2021
por: Giuliano, Anna R., et al.
Publicado: (2022) -
Responses to Sars-Cov-2 Vaccines in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia
por: Jain, Akriti G, et al.
Publicado: (2021)